{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:09:07Z","timestamp":1783973347760,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtha.2026.01.013","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:38:21Z","timestamp":1770424701000},"page":"1823-1826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From bench to bedside: the untold story behind the clinical development of enoxaparin"],"prefix":"10.1016","volume":"24","author":[{"given":"Jack","family":"Hirsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9491-6172","authenticated-orcid":false,"given":"Noel","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.01.013_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood.V49.2.171.171","article-title":"Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis","volume":"49","author":"Chiu","year":"1977","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.013_bib2","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1073\/pnas.69.11.3469","article-title":"Enzymic depolymerization of macromolecular heparin as a factor in control of lipoprotein lipase activity","volume":"69","author":"Horner","year":"1972","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2026.01.013_bib3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/blood.V59.6.1239.1239","article-title":"The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits","volume":"59","author":"Carter","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.013_bib4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM198610093151503","article-title":"A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery","volume":"315","author":"Turpie","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.013_bib5","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism","volume":"2","author":"Robertson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2026.01.013_bib6","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.ATV.17.8.1568","article-title":"Induction of the acute-phase reaction increases heparin-binding proteins in plasma","volume":"17","author":"Young","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2026.01.013_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0038-1648515","article-title":"Heparin binding to plasma proteins, an important mechanism for heparin resistance","volume":"67","author":"Young","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.013_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-2143(97)90115-3","article-title":"The variable anticoagulant response to unfractionated heparin in vivo reflects binding to plasma proteins rather than clearance","volume":"130","author":"Manson","year":"1997","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jtha.2026.01.013_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.95.1.118","article-title":"Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate","volume":"95","author":"Cosmi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.01.013_bib10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.013_bib11","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1378\/chest.07-1553","article-title":"So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?","volume":"132","author":"Warkentin","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.01.013_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-114-7-545","article-title":"Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin","volume":"114","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2026.01.013_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-121-2-199407150-00001","article-title":"Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group","volume":"121","author":"Spiro","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2026.01.013_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2106\/00004623-199401000-00002","article-title":"Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety","volume":"76","author":"Colwell","year":"1994","journal-title":"Enoxaparin Clinical Trial Group. J Bone Joint Surg Am"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:56:58Z","timestamp":1783972618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538783626000681"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.013","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From bench to bedside: the untold story behind the clinical development of enoxaparin","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}